CATZEYA
Live / Allowed — Publication / registration review complete (as of 16 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 50071028
- Mark type
- Word mark
- Kind
- Trademark
- Register
- Principal
- Basis
- Intent to use (§1(b))
- Filed
- 25 Aug 2026
- Published for opposition
- 08 Dec 2026
- Examining attorney
- Michael Eisnach
- Attorney of record
- Jeffrey J. Scepanski
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 04 Nov 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2026 — ASSIGNED TO EXAMINER
- 25 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Aug 2026 — NEW APPLICATION ENTERED